RP-3500 clinical trials

Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors

This study is testing a new medicine called lunresertib, by itself or with other medicines (RP-3500 or Debio 0123), for people with advanced solid tumours. It aims to see if they are safe, what dose works best, and if they help shrink tumours.